Abstract
Mass spectrometry imaging is a technique that measures the composition of tissue slices and can visualise the distribution of different components from tissue. This way, for example, the distribution of drugs can be shown or a distinction can be made between healthy and diseased tissue. This thesis aimed towards getting the imaging procedure within a clinical timeframe through the development of a new sample preparation device, where the whole workflow was reduced from 90 minutes to less than half an hour. Furthermore, it describes a new method to quantify drugs in tissue, which aids in visualizing how drugs are absorbed into tissue. Finally, the technique was used to study biopsies of cholangiocarcinoma patients. Here, a link was found between a high level of unsaturated versus saturated sulfatides (a specific type of lipids) and a poorer survival outcome.
| Original language | English |
|---|---|
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 15 Jun 2022 |
| Place of Publication | Maastricht |
| Publisher | |
| DOIs | |
| Publication status | Published - 2022 |
Keywords
- mass spectrometry
- molecular diagnostics
- drug quantification
- cholangiocarcinoma
Fingerprint
Dive into the research topics of 'High resolution mass spectrometry imaging for pharmaceutical and clinical applications'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver